HL7 Terminology (THO)
6.5.30 - Continuous Process Integration (ci build)
HL7 Terminology (THO), published by HL7 International - Vocabulary Work Group. This guide is not an authorized publication; it is the continuous build for version 6.5.30 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/UTG/ and changes regularly. See the Directory of published versions
| Official URL: http://terminology.hl7.org/ValueSet/v2-0227 | Version: 4.0.0 | |||
| Active as of 2023-06-12 | Responsible: Health Level Seven International | Computable Name: PHVSManufacturersOfVaccinesMVXCDCNIP | ||
| Other Identifiers: OID:2.16.840.1.114222.4.11.826 | ||||
Copyright/Legal: This material derives from the HL7 Terminology (THO). THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html |
||||
Value Set of codes that specify the organization that manufactures a vaccine. The values are maintained by the US Centers of Disease Control. Note that the source of truth for these code values are maintained by the CDC, and the code system may be accessed via https://phinvads.cdc.gov/vads/ViewCodeSystem.action?id=2.16.840.1.113883.12.227
References
This value set is not used here; it may be used elsewhere (e.g. specifications and/or implementations that use this content)
Expansion performed internally based on codesystem MVX - Manufacturers of Vaccines v20201030 (CodeSystem)
This value set contains 82 concepts
| System | Code | Display (en) | Definition | JSON | XML |
http://hl7.org/fhir/sid/mvx | AB | Abbott Laboratories | |||
http://hl7.org/fhir/sid/mvx | ACA | Acambis, Inc | |||
http://hl7.org/fhir/sid/mvx | AD | Adams Laboratories, Inc. | |||
http://hl7.org/fhir/sid/mvx | ALP | Alpha Therapeutic Corporation | |||
http://hl7.org/fhir/sid/mvx | AR | Armour | |||
http://hl7.org/fhir/sid/mvx | AVB | Aventis Behring L.L.C. | |||
http://hl7.org/fhir/sid/mvx | AVI | Aviron | |||
http://hl7.org/fhir/sid/mvx | BA | Baxter Healthcare Corporation-inactive | |||
http://hl7.org/fhir/sid/mvx | BAH | Baxter Healthcare Corporation | |||
http://hl7.org/fhir/sid/mvx | BAY | Bayer Corporation | |||
http://hl7.org/fhir/sid/mvx | BP | Berna Products | |||
http://hl7.org/fhir/sid/mvx | BPC | Berna Products Corporation | |||
http://hl7.org/fhir/sid/mvx | BTP | Biotest Pharmaceuticals Corporation | |||
http://hl7.org/fhir/sid/mvx | MIP | Emergent BioSolutions | |||
http://hl7.org/fhir/sid/mvx | CSL | bioCSL | |||
http://hl7.org/fhir/sid/mvx | CNJ | Cangene Corporation | |||
http://hl7.org/fhir/sid/mvx | CMP | Celltech Medeva Pharmaceuticals | |||
http://hl7.org/fhir/sid/mvx | CEN | Centeon L.L.C. | |||
http://hl7.org/fhir/sid/mvx | CHI | Chiron Corporation | |||
http://hl7.org/fhir/sid/mvx | CON | Connaught | |||
http://hl7.org/fhir/sid/mvx | DVC | DynPort Vaccine Company, LLC | |||
http://hl7.org/fhir/sid/mvx | EVN | Evans Medical Limited | |||
http://hl7.org/fhir/sid/mvx | GEO | GeoVax Labs, Inc. | |||
http://hl7.org/fhir/sid/mvx | SKB | GlaxoSmithKline | |||
http://hl7.org/fhir/sid/mvx | GRE | Greer Laboratories, Inc. | |||
http://hl7.org/fhir/sid/mvx | IAG | Immuno International AG | |||
http://hl7.org/fhir/sid/mvx | IUS | Immuno-U.S., Inc. | |||
http://hl7.org/fhir/sid/mvx | INT | Intercell Biomedical | |||
http://hl7.org/fhir/sid/mvx | KGC | Korea Green Cross Corporation | |||
http://hl7.org/fhir/sid/mvx | LED | Lederle | |||
http://hl7.org/fhir/sid/mvx | MBL | Massachusetts Biologic Laboratories | |||
http://hl7.org/fhir/sid/mvx | MA | Massachusetts Public Health Biologic Laboratories | |||
http://hl7.org/fhir/sid/mvx | MED | MedImmune, Inc. (AstraZeneca) | |||
http://hl7.org/fhir/sid/mvx | MSD | Merck and Co., Inc. | |||
http://hl7.org/fhir/sid/mvx | IM | Merieux | |||
http://hl7.org/fhir/sid/mvx | MIL | Miles | |||
http://hl7.org/fhir/sid/mvx | NAB | NABI | |||
http://hl7.org/fhir/sid/mvx | NYB | New York Blood Center | |||
http://hl7.org/fhir/sid/mvx | NAV | North American Vaccine, Inc. | |||
http://hl7.org/fhir/sid/mvx | NOV | Novartis Pharmaceutical Corporation | |||
http://hl7.org/fhir/sid/mvx | NVX | Novavax, Inc. | |||
http://hl7.org/fhir/sid/mvx | OTC | Organon Teknika Corporation | |||
http://hl7.org/fhir/sid/mvx | ORT | Ortho-clinical Diagnostics | |||
http://hl7.org/fhir/sid/mvx | PD | Parkedale Pharmaceuticals | |||
http://hl7.org/fhir/sid/mvx | PWJ | PowderJect Pharmaceuticals | |||
http://hl7.org/fhir/sid/mvx | PRX | Praxis Biologics | |||
http://hl7.org/fhir/sid/mvx | JPN | The Research Foundation for Microbial Diseases of Osaka University (BIKEN) | |||
http://hl7.org/fhir/sid/mvx | PMC | Sanofi Pasteur | |||
http://hl7.org/fhir/sid/mvx | SCL | Sclavo, Inc. | |||
http://hl7.org/fhir/sid/mvx | SOL | Solvay Pharmaceuticals | |||
http://hl7.org/fhir/sid/mvx | SI | Swiss Serum and Vaccine Inst. | |||
http://hl7.org/fhir/sid/mvx | TAL | Talecris Biotherapeutics | |||
http://hl7.org/fhir/sid/mvx | USA | United States Army Medical Research and Material Command | |||
http://hl7.org/fhir/sid/mvx | VXG | VaxGen | |||
http://hl7.org/fhir/sid/mvx | WA | Wyeth-Ayerst | |||
http://hl7.org/fhir/sid/mvx | WAL | Wyeth | |||
http://hl7.org/fhir/sid/mvx | ZLB | ZLB Behring | |||
http://hl7.org/fhir/sid/mvx | OTH | Other manufacturer | |||
http://hl7.org/fhir/sid/mvx | UNK | Unknown manufacturer | |||
http://hl7.org/fhir/sid/mvx | AKR | Akorn, Inc | |||
http://hl7.org/fhir/sid/mvx | PFR | Pfizer, Inc | |||
http://hl7.org/fhir/sid/mvx | BRR | Barr Laboratories | |||
http://hl7.org/fhir/sid/mvx | JNJ | Johnson and Johnson | |||
http://hl7.org/fhir/sid/mvx | PSC | Protein Sciences | |||
http://hl7.org/fhir/sid/mvx | IDB | ID Biomedical | |||
http://hl7.org/fhir/sid/mvx | GRF | Grifols | |||
http://hl7.org/fhir/sid/mvx | CRU | Crucell | |||
http://hl7.org/fhir/sid/mvx | KED | Kedrion Biopharma | |||
http://hl7.org/fhir/sid/mvx | PAX | PaxVax | |||
http://hl7.org/fhir/sid/mvx | MCM | MCM Vaccine Company | |||
http://hl7.org/fhir/sid/mvx | SEQ | Seqirus | |||
http://hl7.org/fhir/sid/mvx | VAL | Valneva | |||
http://hl7.org/fhir/sid/mvx | DYN | Dynaport | |||
http://hl7.org/fhir/sid/mvx | DVX | Dynavax, Inc. | |||
http://hl7.org/fhir/sid/mvx | DSI | Dispensing Solutions | |||
http://hl7.org/fhir/sid/mvx | REB | Rebel Distributors | |||
http://hl7.org/fhir/sid/mvx | VET | Vetter Pharma Fertigung GmbH & Co. KG | |||
http://hl7.org/fhir/sid/mvx | TVA | TEVA Pharmaceuticals USA | |||
http://hl7.org/fhir/sid/mvx | BN | Bavarian Nordic A/S | |||
http://hl7.org/fhir/sid/mvx | MOD | Moderna US, Inc. | |||
http://hl7.org/fhir/sid/mvx | ASZ | AstraZeneca | |||
http://hl7.org/fhir/sid/mvx | JSN | Janssen |
Explanation of the columns that may appear on this page:
| Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
| System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance) |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |
History
| Date | Action | Custodian | Author | Comment |
| 2023-11-14 | revise | TSMG | Marc Duteau | Add standard copyright and contact to internal content; up-476 |
| 2020-05-06 | revise | Vocabulary WG | Ted Klein | Migrated to the UTG maintenance environment and publishing tooling. |